News

Cardiff University scientists discover compound capable of fighting cancer on multiple fronts.

Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.

A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.

Evidence continues to surface that supports the premise that antibiotics which have been out of use could still be effective in treating drug-resistant bacteria.

A new study shows that it is possible to use an imaging technique called cryo-electron microscopy to view the architecture of a metabolic enzyme bound to a drug that blocks its activity.

For the first time, scientists have identified an existing drug that slows the growth of the deadliest childhood brain tumor.

NIH-funded research finds therapeutic hypothermia no more effective than normal temperature control.

A study led by University of Missouri researchers has determined that a compound found in green tea, and voluntary exercise, slows the progression of the disease in mice and may actually reverse its effects.

The deal structure involves CAD$50 million in equity investments, and future China sales milestones and licensing royalties that could represent in excess of US$400 million.

Company partnering with customers to expand the use of inhalation technologies to treat a wider range of diseases.